CPS
VRTX icon

Counsel Portfolio Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Counsel Portfolio Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-28,949
Closed -$3.02M – 291
2015
Q3 		$3.02M Hold
28,949
– – 0.33% 92
2015
Q2 		$3.58M Hold
28,949
– – 0.36% 91
2015
Q1 		$3.42M Buy
+28,949
New +$3.47M 0.34% 101

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Counsel Portfolio Services's VRTX Position: Q4 2015 in Review

Counsel Portfolio Services sold out of Vertex Pharmaceuticals (VRTX) in Q4 2015, closing a stake of 28,949 shares — an estimated $3.02M sold.

Counsel Portfolio Services first reported a position in VRTX in Q1 2015 and held it in 3 quarters. The position peaked at $3.58M in Q2 2015. 517 funds tracked by Wall St. Rank hold VRTX as of Q4 2015.

  • Counsel Portfolio Services reported no remaining Vertex Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Counsel Portfolio Services sold 28,949 Vertex Pharmaceuticals shares in Q4 2015, an estimated $3.02M.
  • Counsel Portfolio Services first reported a position in Vertex Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Counsel Portfolio Services's Vertex Pharmaceuticals position peaked at $3.58M in Q2 2015.
  • 517 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2015.

Based on Counsel Portfolio Services's 13F filing for Q4 2015, filed 12 Feb 2016.